{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T16:40:58Z","timestamp":1777653658879,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We present the case of a 14-year-old who established care at our primary care clinic after hospitalization for unintentional fentanyl overdose. They were diagnosed with severe opioid use disorder (OUD) and stimulant use disorder (StUD) and initiated buprenorphine while inpatient. They were then transitioned to the only known outpatient primary care clinic in her county who was actively providing medications for opioid use disorder (MOUD) in adolescents.<\/jats:p><jats:p>At the first visit, they reported a history of 20 overdoses, struggling with adherence to buprenorphine and continued opioid cravings. An overdose safety plan was reviewed with them and their parent including providing them naloxone kits, fentanyl test strips, and education handout sheets. Due to their significant overdose history and adherence challenges with sublingual buprenorphine, they were started on long-acting injectable buprenorphine (LAIB) with weekly provider visits and urine toxicology screening. In collaboration with the treatment team, they initiated behavioral treatment with contingency management (CM), with incentives for appointment completion, expected urine results, and successful medication administration. Over the next 19 months, and to date, they have increasingly engaged with care and have remained abstinent. LAIB may be an appealing alternative for adolescents with OUD to improve adherence and reduce risk of recurrent use and overdose. Adjunctive treatment with CM may improve retention in MOUD and have the benefit of treating StUD. There is a need for further research to explore innovative, community-based treatment for youth with OUD.<\/jats:p>","DOI":"10.1186\/s13722-024-00487-1","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T11:01:44Z","timestamp":1721386904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A case of severe opioid and methamphetamine use disorder in a 14 year old"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6481-3946","authenticated-orcid":false,"given":"Nadia","family":"Allami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah M.","family":"Bagley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,19]]},"reference":[{"issue":"14","key":"487_CR1","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1001\/jama.2022.2847","volume":"327","author":"J Friedman","year":"2022","unstructured":"Friedman J, Godvin M, Shover CL, Gone JP, Hansen H, Schriger DL. Trends in Drug Overdose deaths among US adolescents, January 2010 to June 2021. JAMA. 2022;327(14):1398\u2013400.","journal-title":"JAMA"},{"issue":"2","key":"487_CR2","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1001\/jamapediatrics.2020.5035","volume":"175","author":"JK Lim","year":"2021","unstructured":"Lim JK, Earlywine JJ, Bagley SM, Marshall BDL, Hadland SE. Polysubstance involvement in opioid overdose deaths in adolescents and young adults, 1999\u20132018. JAMA Pediatr. 2021;175(2):194\u20136.","journal-title":"JAMA Pediatr"},{"issue":"Suppl 2","key":"487_CR3","doi-asserted-by":"publisher","first-page":"S153","DOI":"10.1542\/peds.2019-2056C","volume":"145","author":"CA Robinson","year":"2020","unstructured":"Robinson CA, Wilson JD. Management of Opioid Misuse and Opioid Use disorders among Youth. Pediatrics. 2020;145(Suppl 2):S153\u201364.","journal-title":"Pediatrics"},{"issue":"5","key":"487_CR4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","volume":"9","author":"K Kampman","year":"2015","unstructured":"Kampman K, Jarvis M. American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of medications in the treatment of Addiction Involving Opioid Use. J Addict Med. 2015;9(5):358\u201367.","journal-title":"J Addict Med"},{"issue":"3","key":"487_CR5","doi-asserted-by":"publisher","first-page":"e20161893","DOI":"10.1542\/peds.2016-1893","volume":"138","author":"COMMITTEE ON SUBSTANCE USE AND PREVENTION","year":"2016","unstructured":"Committee on Substance Use and Prevention. Medication-assisted treatment of adolescents with opioid Use disorders. Pediatrics. 2016;138(3):e20161893.","journal-title":"Pediatrics"},{"issue":"3","key":"487_CR6","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jadohealth.2020.12.129","volume":"68","author":"SE Hadland","year":"2021","unstructured":"Hadland SE, Aalsma MC, Akg\u00fcl S, Alinsky RH, Bruner A, Chadi N, et al. Medication for adolescents and young adults with opioid Use Disorder. J Adolesc Health off Publ Soc Adolesc Med. 2021;68(3):632\u20136.","journal-title":"J Adolesc Health off Publ Soc Adolesc Med"},{"key":"487_CR7","unstructured":"AACAP. Opioid Use Disorder Treatment for Youth. [cited 2024 May 24]. https:\/\/www.aacap.org\/AACAP\/Policy_Statements\/2020\/Opioid_Use_Disorder_Treatment_Youth.aspx."},{"issue":"2","key":"487_CR8","doi-asserted-by":"publisher","first-page":"e2022058755","DOI":"10.1542\/peds.2022-058755","volume":"151","author":"A Terranella","year":"2023","unstructured":"Terranella A, Guy GP, Mikosz C. Buprenorphine Dispensing among Youth aged\u2009\u2264\u200919 years in the United States: 2015\u20132020. Pediatrics. 2023;151(2):e2022058755.","journal-title":"Pediatrics"},{"issue":"10","key":"487_CR9","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/jamapsychiatry.2021.1969","volume":"78","author":"HA Bol\u00edvar","year":"2021","unstructured":"Bol\u00edvar HA, Klemperer EM, Coleman SRM, DeSarno M, Skelly JM, Higgins ST. Contingency management for patients receiving medication for opioid use disorder: a systematic review and Meta-analysis. JAMA Psychiatry. 2021;78(10):1092\u2013102.","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"487_CR10","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.pcl.2019.08.007","volume":"66","author":"C Stanger","year":"2019","unstructured":"Stanger C, Budney AJ. Contingency management: using incentives to improve outcomes for adolescent substance Use disorders. Pediatr Clin North Am. 2019;66(6):1183\u201392.","journal-title":"Pediatr Clin North Am"},{"issue":"11","key":"487_CR11","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1111\/j.1360-0443.2006.01581.x","volume":"101","author":"M Prendergast","year":"2006","unstructured":"Prendergast M, Podus D, Finney J, Greenwell L, Roll J. Contingency management for treatment of substance use disorders: a meta-analysis. Addict Abingdon Engl. 2006;101(11):1546\u201360.","journal-title":"Addict Abingdon Engl"},{"issue":"4","key":"487_CR12","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1001\/jamapediatrics.2023.6493","volume":"178","author":"SE Hadland","year":"2024","unstructured":"Hadland SE, Burr WH, Zoucha K, Somberg CA, Camenga DR. Treating adolescent opioid Use Disorder in Primary Care. JAMA Pediatr. 2024;178(4):414\u20136.","journal-title":"JAMA Pediatr"}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-024-00487-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-024-00487-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-024-00487-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T11:12:06Z","timestamp":1721387526000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/s13722-024-00487-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,19]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["487"],"URL":"https:\/\/doi.org\/10.1186\/s13722-024-00487-1","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,19]]},"assertion":[{"value":"22 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained by the case study participant and their legal guardian.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors have indicated they have no conflicts of interest relevant to this article to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest disclosures"}},{"value":"Treating adolescents with opioid use disorder and stimulant use disorder with an evidence-based approach in a pediatric primary care clinic.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Article summary"}}],"article-number":"54"}}